Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Greenbaum

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Diabetes Care|April 28, 2005
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, et al.
Diabetes|October 31, 2009
Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjectsS Alice Long, Karen Cerosaletti, Paul L Bollyky, et al.
Pediatric Diabetes|June 11, 2004
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?Desmond Schatz, David Cuthbertson, Mark Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetesMaria J Redondo, Sunanda Babu, Adina Zeidler, et al.
Pediatric Diabetes|April 16, 2014
Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yrMarie Louise Max Andersen, Lotte B Nielsen, Jannet Svensson, et al.
Clinical Immunology (Orlando, Fla.)|May 16, 2009
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 yearsKevan C Herold, Stephen Gitelman, Carla Greenbaum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2011
Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variantTania Habib, Andrew Funk, Mary Rieck, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2011
Effect of rituximab on human in vivo antibody immune responsesMark D Pescovitz, Troy R Torgerson, Hans D Ochs, et al.
Diabetes|March 22, 2019
Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D ProgressionTania Habib, S Alice Long, Peter L Samuels, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 7, 2013
The influence of exposure to maternal diabetes in utero on the rate of decline in β-cell function among youth with diabetesTessa L Crume, Jeanette S Andrews, Ralph B D'Agostino, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Diabetes Care|April 28, 2005
Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1Jay S Skyler, Jeffrey P Krischer, Joseph Wolfsdorf, et al.
Diabetes|October 31, 2009
Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjectsS Alice Long, Karen Cerosaletti, Paul L Bollyky, et al.
Pediatric Diabetes|June 11, 2004
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?Desmond Schatz, David Cuthbertson, Mark Atkinson, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetesMaria J Redondo, Sunanda Babu, Adina Zeidler, et al.
Pediatric Diabetes|April 16, 2014
Disease progression among 446 children with newly diagnosed type 1 diabetes located in Scandinavia, Europe, and North America during the last 27 yrMarie Louise Max Andersen, Lotte B Nielsen, Jannet Svensson, et al.
Clinical Immunology (Orlando, Fla.)|May 16, 2009
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb Teplizumab preserves insulin production for up to 5 yearsKevan C Herold, Stephen Gitelman, Carla Greenbaum, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2011
Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variantTania Habib, Andrew Funk, Mary Rieck, et al.
The Journal of Allergy and Clinical Immunology|September 13, 2011
Effect of rituximab on human in vivo antibody immune responsesMark D Pescovitz, Troy R Torgerson, Hans D Ochs, et al.
Diabetes|March 22, 2019
Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D ProgressionTania Habib, S Alice Long, Peter L Samuels, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|May 7, 2013
The influence of exposure to maternal diabetes in utero on the rate of decline in β-cell function among youth with diabetesTessa L Crume, Jeanette S Andrews, Ralph B D'Agostino, et al.
Pageof 5